Vical - 48 Year Dividend Yield History | VICL

Historical dividend payout and yield for Vical (VICL) since 1971. The current TTM dividend payout for Vical (VICL) as of March 19, 2019 is $0.00. The current dividend yield for Vical as of March 19, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.025B $0.002B
Vical researches and develops biopharmaceutical products based on its patented DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases. Potential applications of the company's DNA delivery technology include DNA vaccines for infectious diseases or cancer, in which the expressed protein is an immunogen; cancer immunotherapeutics, in which the expressed protein is an immune system stimulant; and cardiovascular therapies, in which the expressed protein is an angiogenic growth factor. The company is developing certain infectious disease vaccines and cancer therapeutics internally. In addition, the company collaborates with major pharmaceutical companies and biotechnology companies that give it access to complementary technologies or greater resources. These strategic partnerships provide the company with mutually beneficial opportunities to expand its product pipeline and address significant unmet medical needs.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $119.048B 13.28
Gilead Sciences (GILD) United States $82.934B 10.56
Bio-Techne Corp (TECH) United States $7.430B 50.06